Telesis Bio, Inc (TBIO) Cash Funds per Single Share

Telesis Bio, Inc. (TBIO) operates in an autonomous cycle, remaining a defensive asset regardless of the global economy. The cash per share trend captures the rate of resource consumption, while the value of 5.80 shows the most recent figure. Telesis Bio, Inc. (TBIO) is implementing DNA/mRNA synthesis automation, leveraging the growth of the gene therapy market. Consumables sales and partnerships with pharma behemoths will serve as the primary catalysts.
Comprehensive metric breakdowns and analytics for Telesis Bio (TBIO)

Bioprinter patents require significant expenditures to integrate equipment into laboratory cycles. This metric determines the share of liquid assets per common share of Telesis Bio, Inc. (TBIO), reflecting the company's actual cash reserves. An increase in this indicator reduces bankruptcy risk, although excess funds may signal inefficient capital management. Analyzing this trend allows for an assessment of the issuer's financial stability. Track the cash per share to monitor solvency.